Rachelle Perea

Rachelle Perea has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Rachelle began their career at Alpha Therapeutics as a Clinical Trial Manager from 1997 to 1999. Rachelle then worked as a Senior Clinical Trial Manager at Biogen Idec from 2002 to 2009. Following that, they joined Pfizer as a Clinical Research Scientist from 2009 to 2011, and then transitioned to the role of Study Clinician from 2011 to 2019. Rachelle later worked at Agios Pharmaceuticals as a Clinical Scientist from 2019 to 2021, before moving on to Gritstone bio as a Clinical Scientist for a brief period from 2021. Currently, they are employed at Kymera Therapeutics as a Senior Director of Clinical Science, starting from September 2021.

Rachelle Perea's education history includes attending the University of San Diego, although the specific degree and field of study are not specified.